Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{603c577281cf42ad930024eb54240f5f,
title = "Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study",
abstract = "A recent randomized controlled trial suggests that hypothyroid subjects may find levothyroxine (l-T4) and levotriiodothyronine combination therapy to be superior to l-T4 monotherapy in terms of quality of life, suggesting that the brain registered increased T3 availability during the combination therapy.",
author = "Ulla Schmidt and Birte Nygaard and {Winther Jensen}, Ebbe and Jan Kvetny and Anne Jarl{\o}v and Jens Faber",
year = "2013",
month = mar,
day = "1",
doi = "10.1530/EC-12-0064",
language = "English",
volume = "2",
pages = "55--60",
journal = "Endocrine Connections",
issn = "2049-3614",
publisher = "BioScientifica Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Peripheral markers of thyroid function

T2 - the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study

AU - Schmidt, Ulla

AU - Nygaard, Birte

AU - Winther Jensen, Ebbe

AU - Kvetny, Jan

AU - Jarløv, Anne

AU - Faber, Jens

PY - 2013/3/1

Y1 - 2013/3/1

N2 - A recent randomized controlled trial suggests that hypothyroid subjects may find levothyroxine (l-T4) and levotriiodothyronine combination therapy to be superior to l-T4 monotherapy in terms of quality of life, suggesting that the brain registered increased T3 availability during the combination therapy.

AB - A recent randomized controlled trial suggests that hypothyroid subjects may find levothyroxine (l-T4) and levotriiodothyronine combination therapy to be superior to l-T4 monotherapy in terms of quality of life, suggesting that the brain registered increased T3 availability during the combination therapy.

U2 - 10.1530/EC-12-0064

DO - 10.1530/EC-12-0064

M3 - Journal article

C2 - 23781319

VL - 2

SP - 55

EP - 60

JO - Endocrine Connections

JF - Endocrine Connections

SN - 2049-3614

IS - 1

ER -

ID: 39014588